Ballicules.com

Levonorgestrel IUD

MIRENA

Pronunciation: lee-voe-nor-JES-trel

Levonorgestrel IUD ballicule: receptor binding, kinetics and half-life diagram
Mechanism of action: Levonorgestrel IUD ballicule
Levonorgestrel IUD MIRENA mascot mnemonic cartoon
Visual mnemonic: Levonorgestrel IUD mascot
“Leave (in for) no gestation”

What it isLevonorgestrel intrauterine system (MIRENA, 2000) locally activates progesterone receptors; contraception for up to 8 years and heavy menstrual bleeding.

Why this oneIts heavy-menstrual-bleeding indication (2009) and up to 8 years of contraception distinguish it from lower-dose levonorgestrel systems.

What limits itIrregular bleeding is expected early; insertion can cause perforation or expulsion, and pregnancy with one in place may be ectopic.

Levonorgestrel IUD molecular structure (skeletal formula)
Molecular structure: Levonorgestrel IUD

FDA-approved for

FDA label

FDA dosingPopulationStartTargetMax
Prevention of pregnancy (intrauterine contraception)Females of reproductive potentialOne intrauterine system (52 mg LNG) inserted; releases ~21 mcg/day after 24 daysSingle deviceRemove/replace by end of the 8th year
Treatment of heavy menstrual bleeding (in women using it for contraception)Females of reproductive potentialOne intrauterine system (52 mg LNG) insertedSingle deviceReplace by end of the 5th year if continued treatment needed

Renal Undefined (no formal studies)

Hepatic Undefined (no formal studies; acute liver disease or liver tumor is a contraindication)

Contraception: replace by end of 8th year; heavy menstrual bleeding: replace by end of 5th year

Instructions

Available strengths

Contraindications

Cautions

Adverse reactions

Pregnancy Contraindicated in pregnancy; may cause adverse pregnancy outcomes (ectopic pregnancy, miscarriage, sepsis, preterm labor/delivery). Remove if pregnancy occurs.

Lactation Levonorgestrel present in human milk (~0.1% of maternal dose); no reported adverse effects in breastfed infants with progestin-only contraceptives; isolated reports of decreased milk production.

Cost

Levonorgestrel IUD (MIRENA)
Strength#/mogeneric $/unitCostPlus
52 mgIUDper unitnot offered
NADAC is a voluntary CMS survey of what retail community pharmacies pay for the drugs they stock. Levonorgestrel IUD is dispensed outside retail pharmacies, so it rarely appears on surveyed invoices.

Other forms: Levonorgestrel (PLAN B)

Available combined with: ethinyl / estradiol / levonorgestrel

NO BOXED WARNINGS

Principal riskEmergency use is less effective at higher body weight

Classes and tags

Clinical profile

Therapeutic safety burden2 / 4
Overdose danger1 / 4
Weight-gain liability0 / 4
Sedation liability0 / 4
QT / Torsades0 / 4
Direct muscarinic antagonism0 / 4
Embryofetal risk0 / 4

Legacy pregnancy categoryX

Defining liabilityVenous thromboembolism and hormone-related adverse effects; estrogen also lowers lamotrigine exposure.

Open Levonorgestrel IUD in the interactive console ↗

Memory aids: interaction avatars

Levonorgestrel IUD CYP3A4 substrate avatar mnemonic
CYP3A4 substrate

Open Levonorgestrel IUD in the interactive console ↗